AREAS OF CONCENTRATION
- Counseling
- Licensing & Transactions
- Litigation
- Alternative Dispute Resolution
- Appellate
- Federal District Court
- Hatch-Waxman
- International Trade Commission
- Patent Interferences
- Patent Prosecution
- Biomedical
- Biology and Biotechnology
- Chemical
- Pharmaceutical
- Unfair Competition
EDUCATION
- The George Washington University Law School, Juris Doctor, 1976
- Indiana University, Bachelor of Science, Chemistry, 1972
ADMISSIONS, COURTS AND MEMBERSHIPS
- District of Columbia
- Commonwealth of Virginia
- Commonwealth of Massachusetts
- Registered to practice before the U.S. Patent and Trademark Office
- American Bar Association
- American Intellectual Property Law Association
- District of Columbia Bar Association
- Fédération Internationale des Conseils en Propriété Industrielle, President, 2006- present; Vice-President, 2003-2006; Biotechnology Committee, 1988-present
PUBLICATIONS
- “Arrested Development: A Round-Up of the Developments in the Recognition and Protection of Traditional Knowledge and Genetic Resources,” World Intellectual Property Review (March 2006)
- Set Patent Rules by Industry?,” Legal Times: IP Supplemental (March 15, 2003)
- Co-author, “Database Protection in the U.K. and the USA : What, if Any, Protection Might Those Who Work So Hard Receive?,” Journal of Commercial Biotechnology, Vol. 9, No. 3 (March 2003)
- Co-author, “Transannular Alkylations of Cyclooctanones,” Journal of Organic Chemistry, Vol. 37
AWARDS AND HONORS
- Named in The International Who’s Who of Patent Lawyers 2010
- Leading lawyer in biotechnology law and intellectual property law, The Best Lawyers in America (2007-2009)
- Named in The Washington Post Magazine’s Best Lawyers List (2008)
- America ’s Leading Lawyers for Business, Chambers USA (2006-2009)
- Named to the Intellectual Asset Management (IAM 250) - The World’s Leading IP Strategists
SPEAKING ENGAGEMENTS
- Federal Rules and E-Discovery Overview in the U.S., FICPI Open Forum, Seville, Spain (November 2007)
- U.S. Model: Effect of Amendments; Estoppel; Scope of Protection; Equivalents; and Means-Plus-Function Claims, FICPI China Symposium, Beijing, China (September 2007)
- Business Method Patents and the Financial Services Industry, SIFMA, New York, NY (February 2007)
- Section 135(b) Anxiety – Is Copying Claims Enough to Keep You Out of 135(b) Trouble?, Boston Patent Law Association (December 2006)
- Partnership Structures and Management, Fédération Internationale des Conseils en Propriété Industrielle (FICPI) 9th Open Forum, Lisbon, Portugal(2005)
- Patent Claim Drafting, Twelfth Work Sessions and Administrative Council meeting of the Asociacion Interamericana de la Propiedad (ASIPI), Punta del Este, Uruguay (2005)
- The Importance of IP Valuation in Intellectual Property Asset Management: A U.S. Viewpoint, Intellectual Property Valuation seminar sponsored by FICPI and LES-AC, Dubai, UAE (2005)
|
R. DANNY HUNTINGTON Member
Danny Huntington is a former chemist for The Gillette Research Institute. He is involved in all phases of intellectual property law, including United States and foreign patent prosecution; litigation in the federal and state courts; licensing; and general client counseling. He has extensive patent interference experience, with particular experience in biotechnology and pharmaceuticals.
Email Attorney
Print Bio
Download Full Bio |